웨어러블 심장 디바이스 시장 비즈니스 기회, 성장요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Wearable Cardiac Devices Market was valued at USD 2.7 billion in 2025 and is estimated to grow at a CAGR of 12.2% to reach USD 8.5 billion by 2035.

The market expansion is driven by a rising global burden of cardiovascular diseases, continuous advancements in wearable health monitoring technologies, and increasing consumer preference for minimally invasive and non-invasive diagnostic solutions. Growing health awareness and a stronger shift toward preventive healthcare are also reinforcing adoption across patient populations. Wearable cardiac devices are advanced medical systems designed to continuously track, diagnose, and manage heart-related conditions outside clinical environments. These devices integrate electrocardiography capabilities, biosensors, wireless communication systems, and digital signal processing technologies to monitor heart rhythm, heart rate, and other cardiovascular indicators in real time. They enable early identification of conditions such as arrhythmias, atrial fibrillation, ischemic abnormalities, and heart failure, allowing timely clinical intervention. Continuous monitoring supports personalized treatment approaches, reduces hospital readmissions, and improves patient outcomes and quality of life. The rising demand for minimally invasive cardiac monitoring solutions is further strengthening market growth as patients and healthcare providers increasingly prefer non-surgical, long-duration monitoring options that reduce discomfort and procedural risks while improving diagnostic efficiency.

The smartwatches segment accounted for 28.5% share in 2025. This segment is widely adopted due to its intuitive interface and ease of use, enabling individuals to independently track cardiac health without continuous clinical supervision. These devices are increasingly equipped with advanced sensor systems and artificial intelligence based analytics, which allow continuous real-time monitoring and support informed clinical decision-making. Advanced algorithmic capabilities also enhance early detection of abnormal cardiac rhythms, including atrial fibrillation, helping reduce the likelihood of severe cardiovascular complications through timely alerts and interventions.

The coronary artery disease segment held a 37.5% share in 2025 and is expected to reach USD 3.3 billion by 2035. Coronary artery disease remains one of the most prevalent cardiovascular conditions globally and is responsible for a significant proportion of heart-related mortality and morbidity. The increasing prevalence of risk factors such as obesity, sedentary lifestyles, unhealthy dietary habits, and tobacco consumption is contributing to a higher disease burden. As these risk factors continue to rise, demand for continuous cardiac monitoring solutions is increasing, thereby accelerating adoption of wearable cardiac devices for early detection and ongoing disease management.

North America Wearable Cardiac Devices Market accounted for 40.4% share in 2025. The region holds a strong position due to the high incidence of cardiovascular diseases, particularly in the U.S. A well-developed healthcare system, advanced medical infrastructure, and strong integration of digital health technologies further support market growth. Widespread availability of modern healthcare facilities, favorable reimbursement structures, and increasing patient awareness are driving the adoption of wearable cardiac devices for early diagnosis, remote monitoring, and long-term disease management across the region.

Major companies operating in the Global Wearable Cardiac Devices Industry include Medtronic, Abbott Laboratories, Koninklijke Philips, Boston Scientific, iRhythm Technologies, ZOLL Medical Corporation, VitalConnect, Cardiac Insight, CardiacSense, Qardio, Welch Allyn, Cardiac Rhythm, Integra LifeSciences, Zimmer Biomet, and Proteus Digital Health. Companies in the Wearable Cardiac Devices Market are focusing on strengthening their competitive position through continuous innovation in sensor accuracy, device miniaturization, and real-time data analytics capabilities. Significant investments in artificial intelligence and machine learning are enabling enhanced predictive diagnostics and improved patient monitoring outcomes. Firms are also expanding cloud-based connectivity features to ensure seamless data transfer between patients and healthcare providers. Strategic collaborations with hospitals, telehealth platforms, and digital health ecosystems are helping improve product integration and market reach. In addition, companies are prioritizing regulatory compliance and clinical validation to enhance product credibility.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation for any one approach
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Product trends
  • 2.2.2 Application trends
  • 2.2.3 End use trends
  • 2.2.4 Regional trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing number of patients suffering from cardiovascular diseases
    • 3.2.1.2 Rapid technological advancements in wearable cardiac devices
    • 3.2.1.3 Growing preference of minimally invasive devices
    • 3.2.1.4 Rising health consciousness and preventive care
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Data privacy issues
    • 3.2.2.2 Stringent regulatory policies
  • 3.2.3 Market opportunities
    • 3.2.3.1 Rapid expansion of home-use wearable cardiac devices
    • 3.2.3.2 Integration with AI and advanced analytics
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape (Driven by primary research)
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology landscape
  • 3.5.1 Current technological trends
    • 3.5.1.1 Continuous ECG and patch based wearable cardiac monitoring devices
    • 3.5.1.2 Cloud integrated remote cardiac monitoring platforms
  • 3.5.2 Emerging technologies
    • 3.5.2.1 Non invasive optical and multimodal biosensing cardiac diagnostics
    • 3.5.2.2 Smart, connected, and personalized wearable cardiac devices
• 3.6 Future market trends (Driven by primary research)
• 3.7 Impact of AI and Generative AI on the market (Driven by primary research)
• 3.8 Pricing analysis, 2025
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 North America
  • 4.2.2 Europe
  • 4.2.3 Asia Pacific
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Holter monitors
• 5.3 Smartwatches
• 5.4 Patch
• 5.5 Defibrillators
• 5.6 Pulse oximeters
• 5.7 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Coronary artery disease (CAD)
• 6.3 Cardiomyopathies
• 6.4 Post-myocardial infarction
• 6.5 Congenital heart diseases
• 6.6 Post-surgical cardiac care
• 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Specialty centers
• 7.4 Home care settings
• 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 UK
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Boston Scientific
• 9.3 Cardiac Insight
• 9.4 CardiacSense
• 9.5 Cardiac Rhythm
• 9.6 iRhythm Technologies
• 9.7 Integra LifeSciences
• 9.8 Koninklijke Philips
• 9.9 Medtronic
• 9.10 Proteus Digital Health
• 9.11 Qardio
• 9.12 ZOLL Medical Corporation
• 9.13 Welch Allyn
• 9.14 VitalConnect
• 9.15 Zimmer Biomet